Salix agrees to Valeant's new offer

Raleigh-based Salix Pharmaceuticals (Nasdaq: SLXP) has announced that it agrees to Valeant Pharmaceuticals' (NYSE: VRX) new terms for a buyout...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.